Expression data from IBS patients before and after treatment - GSE14842
Increased numbers of mast cells and their products have been linked to symptom onset and severity in patients with chronic diarrhea and abdominal pain. Although mast-cell inhibition ameliorates clinical manifestations and reduces mucosal inflammation, underlying molecular mechanisms remain unknown.
--
Diarrhea-irritable bowel syndrome (d-IBS) patients were studied at baseline, or 6 months after natural evolution (control) or oral cromoglycate treatment. Jejunal biopsies were subjected to chip analysis (Affymetrix Human Genome U133 Plus 2.0 GeneChips).
Oral cromoglycate treatment
Natural evolution of the disease
Chip analysis were done on jejunal biopsies of 5 Diarrhea-irritable bowel syndrome (d-IBS) patients at baseline, 6 months after natural evolution (control) or oral cromoglycate treatment.
--
Sample ID | tissue | treatment | disease | location | Sample Type |
---|---|---|---|---|---|
GSM371301 | jejunal mucosa | baseline | diarrhea-IBS | 10 cm from Treitz | Jejunal biopsy |
GSM371302 | jejunal mucosa | baseline | diarrhea-IBS | 10 cm from Treitz | Jejunal biopsy |
GSM371303 | jejunal mucosa | baseline | diarrhea-IBS | 10 cm from Treitz | Jejunal biopsy |
GSM371304 | jejunal mucosa | baseline | diarrhea-IBS | 10 cm from Treitz | Jejunal biopsy |
GSM371305 | jejunal mucosa | baseline | diarrhea-IBS | 10 cm from Treitz | Jejunal biopsy |
All fields are editable except the "Sample ID" column. To edit a cell, click within the cell. To edit a "date" cell, click on the calendar icon. To cancel an edit, press the ESC key.
Sample ID | Tissue | Treatment | Disease | Location | Sample Type | Repetition |
---|---|---|---|---|---|---|
GSM371301 | jejunal mucosa |
baseline |
diarrhea-IBS |
10 cm from Treitz |
Jejunal biopsy |
rep1 |
GSM371302 | jejunal mucosa |
baseline |
diarrhea-IBS |
10 cm from Treitz |
Jejunal biopsy |
rep2 |
GSM371303 | jejunal mucosa |
baseline |
diarrhea-IBS |
10 cm from Treitz |
Jejunal biopsy |
rep3 |
GSM371304 | jejunal mucosa |
baseline |
diarrhea-IBS |
10 cm from Treitz |
Jejunal biopsy |
rep4 |
GSM371305 | jejunal mucosa |
baseline |
diarrhea-IBS |
10 cm from Treitz |
Jejunal biopsy |
rep5 |
GSM371310 | jejunal mucosa |
control |
diarrhea-IBS |
10 cm from Treitz |
Jejunal biopsy |
rep1 |
GSM371311 | jejunal mucosa |
control |
diarrhea-IBS |
10 cm from Treitz |
Jejunal biopsy |
rep2 |
GSM371312 | jejunal mucosa |
control |
diarrhea-IBS |
10 cm from Treitz |
Jejunal biopsy |
rep3 |
GSM371313 | jejunal mucosa |
control |
diarrhea-IBS |
10 cm from Treitz |
Jejunal biopsy |
rep4 |
GSM371314 | jejunal mucosa |
control |
diarrhea-IBS |
10 cm from Treitz |
Jejunal biopsy |
rep5 |
GSM371315 | jejunal mucosa |
treatment |
diarrhea-IBS |
10 cm from Treitz |
Jejunal biopsy |
rep1 |
GSM371316 | jejunal mucosa |
treatment |
diarrhea-IBS |
10 cm from Treitz |
Jejunal biopsy |
rep2 |
GSM371317 | jejunal mucosa |
treatment |
diarrhea-IBS |
10 cm from Treitz |
Jejunal biopsy |
rep3 |
GSM371318 | jejunal mucosa |
treatment |
diarrhea-IBS |
10 cm from Treitz |
Jejunal biopsy |
rep4 |
Name | ||
---|---|---|
All Samples | View | |
Patient | View | |
Treatment | Default | View |
In order to make new Group Sets or change settings, please log in. |
Group Set | |
---|---|
All Samples | |
Patient | |
Treatment |